GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Effective Interest Rate on Debt %

Pharmaresearch Bio Co (XKRX:217950) Effective Interest Rate on Debt % : 12.98% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Pharmaresearch Bio Co's annualized positive value of Interest Expense for the quarter that ended in Dec. 2023 was ₩2,748 Mil. Pharmaresearch Bio Co's average total debt for the quarter that ended in Dec. 2023 was ₩21,178 Mil. Therefore, Pharmaresearch Bio Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 was 12.98%.


Pharmaresearch Bio Co Effective Interest Rate on Debt % Historical Data

The historical data trend for Pharmaresearch Bio Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Effective Interest Rate on Debt % Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Effective Interest Rate on Debt %
Get a 7-Day Free Trial 6.35 8.31 4.62 15.30 12.98

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Effective Interest Rate on Debt % Get a 7-Day Free Trial 6.35 8.31 4.62 15.30 12.98

Competitive Comparison of Pharmaresearch Bio Co's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Pharmaresearch Bio Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmaresearch Bio Co's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Pharmaresearch Bio Co's Effective Interest Rate on Debt % falls into.



Pharmaresearch Bio Co Effective Interest Rate on Debt % Calculation

Pharmaresearch Bio Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2022 )+Total Debt  (A: Dec. 2023 ))/ count )
=-1  *  -2748.01/( (20413.208+21943.623)/ 2 )
=-1  *  -2748.01/21178.4155
=12.98 %

where

Total Debt  (A: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=16904.049 + 3509.159
=20413.208

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=489.972 + 21453.651
=21943.623

Pharmaresearch Bio Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2022 )+Total Debt  (Q: Dec. 2023 ))/ count )
=-1  *  -2748.01/( (20413.208+21943.623)/ 2 )
=-1  *  -2748.01/21178.4155
=12.98 %

where

Total Debt  (Q: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=16904.049 + 3509.159
=20413.208

Total Debt  (Q: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=489.972 + 21453.651
=21943.623

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is one times the annual (Dec. 2023) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Pharmaresearch Bio Co  (XKRX:217950) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Pharmaresearch Bio Co Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaresearch Bio Co (XKRX:217950) Business Description

Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines